Celiac Disease Market Reports

1
Celiac Disease Market Insights
2
Summary

• Celiac Disease (CD)- Market Insights,
  Epidemiology and Market Forecast-2023-EU5 report
  provides an overview of the disease and global
  market size of the Celiac Disease for the EU5
  countries (France, Germany, Italy, Spain and
  UK)). It also includes historical and forecasted
  epidemiological data for the total prevalent and
  diagnosed prevalent cases of Celiac Disease in
  EU5 from 2013-2023.

3

• Celiac disease is a genetic autoimmune disease
  where
• the indigestion of gluten leads to damage in the
  
• small intestine. The number of ways
• celiac disease can affect patients, combined with
  a
• lack of training in medical schools and primary
• care residency programs, contributes to the poor
• diagnosis rate. Currently it is estimated that
  80
• of the celiac disease population remains
  undiagnosed.

4
(No Transcript)
5

• Prevalence in Western Europe ranges between 1 in
  133. It is higher in relatives of people with
  celiac disease. Women are affected more commonly
  than men, but there is no age predilection. This
  report forecasts predict that the total prevalent
  cases of Celiac Disease in EU5 is expected to
  accentuate up to 3.2 Million by 2023 at a
  Compound Annual Growth Rate (CAGR) of 2.21 from
  2013-2023, while the diagnosed prevalent
  population of Celiac Disease shall grow at a CAGR
  of 2.86 for the forecast period (2013-2023).

6

• There is no targeted therapy approved for celiac
  disease. The current standard of care treatment
  involves a gluten free diet (GFD). Steroids and
  immunosuppressants are used to reduce symptoms in
  severe cases. Owing to the expected launch of
  Larazotide Acetate (Innovate Pharmaceuticals) in
  2021 followed by the launch of Latiglutenase
• (ImmunogenX/Abbvie) in 2023, shall lead to a hike
• in the otherwise stable,market size of celiac
  disease.
• estimates suggest that the EU5 market size
• is expected to grow at a CAGR of 49.3
• from 2013-2023.

7
Scope

• Report covers the disease overview including
  pathophysiology, symptoms, diagnosis, disease
  management, and current treatment options.
• It focuses on the detailed historical and
  forecasted number of total prevalent cases as
  well as diagnosed prevalent cases of Celiac
  Disease for EU5 countries from 2013-2023.
• It provides the information of available
  marketed therapies, including off-label
  biologics, patent and exclusivity details.
• The report also focuses on the details of
  pipeline
• drugs in the pivotal stage of development
• including their SWOT Analysis and expected
• launch date, which shall help to predict the
• impact of those drugs on the market size in
• the near future.

8
Table of content

• Report Introduction
• Celiac Disease Overview
• Celiac Disease Types
• Non-Responsive or Refractory CD
• Etiology
• Symptoms
• Diagnosis
• Disease Management
• Disease Treatment
• Treatment of Celiac Disease

9
Full Report Celiac Disease Market Insights

• Bharat Book Bureau
• Tel [phone]
• Email poonam_at_bharatbook.com
• Website www.bharatbook.com
• FaceBook BharatBook3B
• Twitter ResearchBook
• LinkedIn Bharat Book Bureau